Production (Stage)
eXoZymes, Inc.
EXOZ
$12.81
-$0.34-2.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.68% | 52.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.64% | 23.06% | |||
| Operating Income | 1.64% | -23.06% | |||
| Income Before Tax | -1.00% | -10.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.11% | -10.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.11% | -10.84% | |||
| EBIT | 1.64% | -23.06% | |||
| EBITDA | 1.85% | -24.17% | |||
| EPS Basic | 9.35% | 7.59% | |||
| Normalized Basic EPS | 9.46% | 7.49% | |||
| EPS Diluted | 9.35% | 7.59% | |||
| Normalized Diluted EPS | 9.46% | 7.49% | |||
| Average Basic Shares Outstanding | 11.58% | 19.95% | |||
| Average Diluted Shares Outstanding | 11.58% | 19.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||